Jansen PJ - Search Results

1

CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification.

Fujimoto M, Fujimoto Y, Poe JC, Jansen PJ, Lowell CA, DeFranco AL, Tedder TF. Fujimoto M, et al. Among authors: jansen pj. Immunity. 2000 Jul;13(1):47-57. doi: 10.1016/s1074-7613(00)00007-8. Immunity. 2000. PMID: 10933394 Free article.

2

CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice.

Sato S, Miller AS, Inaoki M, Bock CB, Jansen PJ, Tang ML, Tedder TF. Sato S, et al. Among authors: jansen pj. Immunity. 1996 Dec;5(6):551-62. doi: 10.1016/s1074-7613(00)80270-8. Immunity. 1996. PMID: 8986715 Free article.

3

CD19 and CD22 expression reciprocally regulates tyrosine phosphorylation of Vav protein during B lymphocyte signaling.

Sato S, Jansen PJ, Tedder TF. Sato S, et al. Among authors: jansen pj. Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13158-62. doi: 10.1073/pnas.94.24.13158. Proc Natl Acad Sci U S A. 1997. PMID: 9371816 Free PMC article.

4

CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.

Fujimoto M, Poe JC, Jansen PJ, Sato S, Tedder TF. Fujimoto M, et al. Among authors: jansen pj. J Immunol. 1999 Jun 15;162(12):7088-94. J Immunol. 1999. PMID: 10358152

5

CD22 forms a quaternary complex with SHIP, Grb2, and Shc. A pathway for regulation of B lymphocyte antigen receptor-induced calcium flux.

Poe JC, Fujimoto M, Jansen PJ, Miller AS, Tedder TF. Poe JC, et al. Among authors: jansen pj. J Biol Chem. 2000 Jun 9;275(23):17420-7. doi: 10.1074/jbc.M001892200. J Biol Chem. 2000. PMID: 10748054 Free article.

6

CD19 expression levels regulate B lymphocyte development: human CD19 restores normal function in mice lacking endogenous CD19.

Sato S, Steeber DA, Jansen PJ, Tedder TF. Sato S, et al. Among authors: jansen pj. J Immunol. 1997 May 15;158(10):4662-9. J Immunol. 1997. PMID: 9144478

7

Isolation and generation of human dendritic cells.

Tedder TF, Jansen PJ. Tedder TF, et al. Among authors: jansen pj. Curr Protoc Immunol. 2001 May;Chapter 7:7.32.1-7.32.16. doi: 10.1002/0471142735.im0732s23. Curr Protoc Immunol. 2001. PMID: 18432844

8

P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells.

Laszik Z, Jansen PJ, Cummings RD, Tedder TF, McEver RP, Moore KL. Laszik Z, et al. Among authors: jansen pj. Blood. 1996 Oct 15;88(8):3010-21. Blood. 1996. PMID: 8874199 Free article.

9

The CLN3 gene is a novel molecular target for cancer drug discovery.

Rylova SN, Amalfitano A, Persaud-Sawin DA, Guo WX, Chang J, Jansen PJ, Proia AD, Boustany RM. Rylova SN, et al. Among authors: jansen pj. Cancer Res. 2002 Feb 1;62(3):801-8. Cancer Res. 2002. PMID: 11830536

10

Flupirtine blocks apoptosis in batten patient lymphoblasts and in human postmitotic CLN3- and CLN2-deficient neurons.

Dhar S, Bitting RL, Rylova SN, Jansen PJ, Lockhart E, Koeberl DD, Amalfitano A, Boustany RM. Dhar S, et al. Among authors: jansen pj. Ann Neurol. 2002 Apr;51(4):448-66. doi: 10.1002/ana.10143. Ann Neurol. 2002. PMID: 11921051

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters